Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls.

Frontiers in endocrinology(2022)

引用 0|浏览2
暂无评分
摘要
The combination of GnRHa with rhGH produced better height gains than GnRHa alone for patients with CPP. The gonadal axis was suppressed and progression of bone age delayed with good safety and efficacy.
更多
查看译文
关键词
central precocious puberty,gonadotropin-releasing hormone analogue,growth velocity,height,predicted adult height,recombinant human growth hormone
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要